ARVN vs EPRX: stock comparison and AI forecast
Arvinas, Inc. (ARVN) and Eupraxia Pharmaceuticals Inc. (EPRX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ARVN Arvinas, Inc.
- Market Cap
- $464M
- P/E Ratio
- 6.5x
- Size
- small-cap
- AI Forecast
EPRX Eupraxia Pharmaceuticals Inc.
- Price
- $6.88 -5.4% · 6M
- Market Cap
- $454M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ARVN and EPRX have similar market capitalizations ($464M and $454M).
- ARVN carries 0.18 times debt per unit of equity, against 0.07 times for EPRX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ARVN | EPRX |
|---|---|---|
| Market Cap | $464M | $454M |
| P/E Ratio | 6.45x | – |
| P/B Ratio | 0.90x | 5.54x |
| EPS | $1.10 | – |
| Book Value/Share | $7.86 | $1.24 |
| Revenue/Share | $3.97 | – |
| FCF/Share | $-2.44 | – |
Profitability & Margins
| Metric | ARVN | EPRX |
|---|---|---|
| ROIC | -6.2% | – |
| Operating Margin | -12.9% | – |
| EBT Margin | -3.4% | – |
| Tax Rate | -6.7% | – |
Financial Health
| Metric | ARVN | EPRX |
|---|---|---|
| Current Ratio | 8.39x | 15.12x |
| D/E Ratio | 0.18x | 0.07x |
| Financial Leverage | 1.18x | 1.05x |
| Interest Coverage | 10.8x | – |
| Working Capital | $518M | $79M |
Cash Flow
| Metric | ARVN | EPRX |
|---|---|---|
| Operating Cash Flow | -$158M | – |
| Free Cash Flow | -$160M | – |
| Capital Spending | -$2M | – |
| FCF/Sales | -61.5% | – |
| CapEx/Sales | 0.6% | – |
Operational Efficiency
| Metric | ARVN | EPRX |
|---|---|---|
| Asset Turnover | 0.43x | – |
| Receivables Turnover | 144.3x | – |
| Fixed Assets Turnover | 56.5x | – |
| Days Sales Outstanding | 3 days | – |
Income Statement
| Metric | ARVN | EPRX |
|---|---|---|
| Total Revenue | $260M | – |
| Operating Income | -$34M | – |
| R&D Expense | $221M | – |
Dividend & Shareholder Information
| Metric | ARVN | EPRX |
|---|---|---|
| Shares Outstanding | 65M | 66M |
ARVN vs EPRX: stock comparison and AI forecast
Which is bigger, ARVN or EPRX?
ARVN and EPRX have similar market capitalizations ($464M and $454M).
Which one does Intratio's AI model rank higher, ARVN or EPRX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.